Nurix Therapeutics, Inc. NRIX Accrued contract research and lab supplies
Accrued contract research and lab supplies at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept nrix:AccruedContractResearchAndLabSupplies.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s accrued contract research and lab supplies.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s accrued contract research and lab supplies?
- Nurix Therapeutics, Inc. (NRIX) reported accrued contract research and lab supplies of $17.59M in Q4 2025.
- How has Nurix Therapeutics, Inc.'s accrued contract research and lab supplies changed year-over-year?
- Nurix Therapeutics, Inc.'s accrued contract research and lab supplies increased by 46.5% year-over-year, from $12M to $17.59M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s accrued contract research and lab supplies?
- Over 2 years (2022 to 2025), Nurix Therapeutics, Inc.'s accrued contract research and lab supplies has grown at a 52.5% compound annual growth rate (CAGR), from $6.43M to $14.95M.
- What does accrued contract research and lab supplies mean?
- This captures the estimated liability for research services performed by third-party contract research organizations and the cost of laboratory supplies consumed but not yet invoiced. It is a critical indicator of the company's current R&D burn rate and the pace of its clinical development pipeline.